SubHero Banner

Tamiflu® (oseltamivir) – First-time generic

August 3, 2016 – The FDA approved Natco Pharma’s AB-rated generic version of Roche’s Tamiflu (oseltamivir) oral capsules, for the treatment of acute, uncomplicated illness due to influenza A and B infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours, and for prophylaxis of influenza A and B in patients 1 year and older.

Download PDF